Toronto, June 15, 2026, 18:06 EDT
- POET Technologies traded recently at $13.93, up $1.39. Nearly 44.7 million shares had traded, much heavier than usual volume.
- POET Technologies hasn’t issued a press release since May 18, when it finished a US$400 million investment. The next investor event for POET is its annual meeting on June 26.
- POET is still a high-risk name. It posted just $503,389 in revenue in Q1 while reporting a $12.3 million net loss. The stock trades on AI data center hopes.
POET Technologies Inc. jumped Monday, as traders looked past profits to the AI-photonics pitch. Shares traded at $13.93, gaining $1.39 for the day. Volume hit 44.7 million, compared to a session low of $12.87 and a high of $15.06. That ran ahead of the SPY ETF, which was up around 1.7%.
POET moves on AI-infrastructure hopes more than on actual revenue growth. Shares go higher when buyers get excited about growth, but they drop just as fast if the company dilutes, misses orders, or posts weak numbers. Bulls are betting on POET’s photonic integrated circuits, chips that link electronics and optics to move data in AI and data centers. The big play from POET is its Optical Interposer platform. It puts photonics and electronics into one module. POET is going after AI, cloud, and data center networks, a market that’s growing fast.
POET’s pipeline and the funding announced in May are both still moving forward. The company raised US$400,000,020 in gross proceeds through a registered direct offering, selling 19,047,620 common shares and a matching number of warrants to one institutional investor, priced at US$21 per security. The warrants have a strike at US$26.25. POET’s plan for the capital is to expand manufacturing, buy other businesses, step up R&D, start new light-source projects, and use some for working capital. “We’re expanding our capacity by roughly ten-fold in both wafer production and optical engine assembly,” CEO Dr. Suresh Venkatesan said. markets.businessinsider.com
POET has secured new cash and unveiled expansion plans after announcing deals with Lumilens, LITEON, and Lessengers. In its Q1 release, POET reported a US$50 million order from Lumilens for EOI-based optical engines. Management said that number could reach US$500 million over five years. Financials still show an early-stage business. Q1 revenue from NRE and product sales came to $503,389, while net loss was $12.3 million, or $0.08 per share. NRE sales are one-time engineering contracts, not the recurring revenue most investors seek—unless those bigger orders show up.
POET is under pressure on execution after it disclosed in April that it lost all its purchase orders from Celestial AI, which is now under Marvell Semiconductor. POET said it lost the orders due to alleged confidentiality breaches. Other shipments are moving, including a $5 million order, the company said. Shareholder litigation alerts are out, asking investors to file for lead-plaintiff status in a federal class action by June 29. That adds legal overhang. POET’s annual meeting is set for June 26, and the U.S. redomicile plan aimed at PFIC tax issues is expected to draw attention.
POET doesn’t look cheap, nor is it obviously fairly valued. Bulls point to its AI data-center photonics business, recent big financing, and buzz about potential large orders. Shares are well off this year’s high of $20.81 and holding above the 52-week low at $3.87. Market cap is $2.4 billion, which is huge compared to Q1 revenue. The valuation depends on converting projected bookings into real revenue. It’s a volatile execution story in semis, not the safest name.
